Medibio science to feature in EC Neurology journal

Company News

by Anna Napoli

Last Movement
$0.008 -$0.001 -11.11%
Data Source:
Last Updated: 19/06/2019 12:35 PM

Mental Health technology company, Medibio (ASX:MEB) has announced that a clinical article on the company has been accepted for publication in EC Neurology.

EC Neurology is an internationally peer-reviewed journal.

The publication highlights Medibio’s scientific success with predicting diagnoses using multinomial logistic regression analysis.

Medibio says the findings reveal a new opportunity to improve the accuracy of psychiatric diagnosis using distinct patterns of mean heart rate and heart rate variability.

Shares in Medibio (ASX:MEB) flat at 14 cents.


Anna Napoli

Finance News Network
Anna joined FNN February 2018 and also works with Channel 7 as a freelance producer. Anna has also worked as a lawyer and lecturer. She has also presented news updates for interstate news with Southern Cross Austereo.